• Bed Bath & Beyond Inc.’s (NASDAQ:BBBY) shares rose 10.5% a day after the retailer projected earnings ahead of Wall Street’s expectations for the fiscal year ending in Feb. 2012
• Drug developer Immunogen Inc. (NASDAQ:IMGN) reported positive results from a mid-stage study of its breast-cancer treatment
• Home-furnishing retailer Pier 1 Imports Inc (NYSE:PIR) reported better-than-expected profit and sales for the fourth quarter and announced plans to buy back up to $100 million in stock
• Late Wednesday, XenoPort Inc. (NASDAQ:XNPT) and GlaxoSmithKline PLC (GSK) announced that they had received regulatory approval for a drug to treat restless-legs syndrome
• Citigroup analysts added semiconductor equipment maker, Lam Research Corp (NASDAQ:LRCX) to the brokerage’s conviction sell list
• Wine and spirits maker Constellation Brands (NYSE:STZ) forecasts its full-year profit above the Street’s view and announced a new stock buyback program
• According to reports, investors may be betting that Coinstar, (NASDAQ:CSTR) the new owners of Blockbuster will close some locations which acts as a positive news for the company’s redbox DVD kiosks
• FBR Capital upgraded salesforce.com, inc (NYSE:CRM) to ‘Outperform’ from ‘Market Perform’ and raised the target price to $170 from $155
BED BATH&BEYOND (BBBY): Free Stock Analysis Report
SALESFORCE.COM (CRM): Free Stock Analysis Report
COINSTAR INC (CSTR): Free Stock Analysis Report
GLAXOSMITHKLINE (GSK): Free Stock Analysis Report
IMMUNOGEN INC (IMGN): Free Stock Analysis Report
LAM RESEARCH (LRCX): Free Stock Analysis Report
PIER 1 IMPORTS (PIR): Free Stock Analysis Report
CONSTELLATN BRD (STZ): Free Stock Analysis Report
XENOPORT INC (XNPT): Free Stock Analysis Report
Zacks Investment Research
